These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 20876809

  • 1. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
    Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, Chen YX, Zhang JP, Zhang X, Wang HY, Xie WF.
    Cancer Res; 2010 Oct 01; 70(19):7640-51. PubMed ID: 20876809
    [Abstract] [Full Text] [Related]

  • 2. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
    Sun W, Ding J, Wu K, Ning BF, Wen W, Sun HY, Han T, Huang L, Dong LW, Yang W, Deng X, Li Z, Wu MC, Feng GS, Xie WF, Wang HY.
    Hepatology; 2011 Oct 01; 54(4):1259-72. PubMed ID: 21735473
    [Abstract] [Full Text] [Related]

  • 3. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang M, Li SN, Anjum KM, Gui LX, Zhu SS, Liu J, Chen JK, Liu QF, Ye GD, Wang WJ, Wu JF, Cai WY, Sun GB, Liu YJ, Liu RF, Zhang ZM, Li BA.
    J Cell Sci; 2013 Dec 15; 126(Pt 24):5692-703. PubMed ID: 24101726
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.
    Yue HY, Yin C, Hou JL, Zeng X, Chen YX, Zhong W, Hu PF, Deng X, Tan YX, Zhang JP, Ning BF, Shi J, Zhang X, Wang HY, Lin Y, Xie WF.
    Gut; 2010 Feb 15; 59(2):236-46. PubMed ID: 19671543
    [Abstract] [Full Text] [Related]

  • 5. Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between Snail and HNF4α during liver stem cell malignant transformation.
    Huang Q, Pu M, Zhao G, Dai B, Bian Z, Tang H, Chen C, Liu W, Qu X, Shen L, Tao K.
    Cancer Lett; 2017 Aug 28; 402():52-60. PubMed ID: 28536011
    [Abstract] [Full Text] [Related]

  • 6. [Hepatocyte nuclear factor 4 (HNF4) in epithelial development and carcinogenesis].
    Lazarevich NL, Al'pern DV.
    Mol Biol (Mosk); 2008 Aug 28; 42(5):786-97. PubMed ID: 18988528
    [Abstract] [Full Text] [Related]

  • 7. Deregulation of hepatocyte nuclear factor 4 (HNF4)as a marker of epithelial tumors progression.
    Lazarevich NL, Shavochkina DA, Fleishman DI, Kustova IF, Morozova OV, Chuchuev ES, Patyutko YI.
    Exp Oncol; 2010 Sep 28; 32(3):167-71. PubMed ID: 21403612
    [Abstract] [Full Text] [Related]

  • 8. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.
    Yin C, Lin Y, Zhang X, Chen YX, Zeng X, Yue HY, Hou JL, Deng X, Zhang JP, Han ZG, Xie WF.
    Hepatology; 2008 Nov 28; 48(5):1528-39. PubMed ID: 18925631
    [Abstract] [Full Text] [Related]

  • 9. Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression.
    Ning BF, Ding J, Liu J, Yin C, Xu WP, Cong WM, Zhang Q, Chen F, Han T, Deng X, Wang PQ, Jiang CF, Zhang JP, Zhang X, Wang HY, Xie WF.
    Hepatology; 2014 Nov 28; 60(5):1607-19. PubMed ID: 24752868
    [Abstract] [Full Text] [Related]

  • 10. Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.
    Yin C, Wang PQ, Xu WP, Yang Y, Zhang Q, Ning BF, Zhang PP, Zhou WP, Xie WF, Chen WS, Zhang X.
    Hepatology; 2013 Dec 28; 58(6):1964-76. PubMed ID: 23775631
    [Abstract] [Full Text] [Related]

  • 11. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
    Park MY, Kim KR, Park HS, Park BH, Choi HN, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS.
    Int J Oncol; 2007 Dec 28; 31(6):1309-15. PubMed ID: 17982656
    [Abstract] [Full Text] [Related]

  • 12. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
    Gotzmann J, Fischer AN, Zojer M, Mikula M, Proell V, Huber H, Jechlinger M, Waerner T, Weith A, Beug H, Mikulits W.
    Oncogene; 2006 May 25; 25(22):3170-85. PubMed ID: 16607286
    [Abstract] [Full Text] [Related]

  • 13. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE.
    Am J Surg Pathol; 2007 May 25; 31(5):681-9. PubMed ID: 17460450
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
    Vallianou I, Dafou D, Vassilaki N, Mavromara P, Hadzopoulou-Cladaras M.
    Int J Biochem Cell Biol; 2016 Sep 25; 78():315-326. PubMed ID: 27477312
    [Abstract] [Full Text] [Related]

  • 15. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
    Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G.
    Cancer Res; 2001 Apr 01; 61(7):3176-81. PubMed ID: 11306505
    [Abstract] [Full Text] [Related]

  • 16. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.
    J Viral Hepat; 2005 Nov 01; 12(6):635-41. PubMed ID: 16255765
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma.
    Jiang CF, Wen LZ, Yin C, Xu WP, Shi B, Zhang X, Xie WF.
    Oncotarget; 2016 May 10; 7(19):27408-21. PubMed ID: 27050273
    [Abstract] [Full Text] [Related]

  • 18. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
    Nagata K, Hirono S, Ido A, Kataoka H, Moriuchi A, Shimomura T, Hori T, Hayashi K, Koono M, Kitamura N, Tsubouchi H.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):205-11. PubMed ID: 11708800
    [Abstract] [Full Text] [Related]

  • 19. The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4α.
    Santangelo L, Marchetti A, Cicchini C, Conigliaro A, Conti B, Mancone C, Bonzo JA, Gonzalez FJ, Alonzi T, Amicone L, Tripodi M.
    Hepatology; 2011 Jun 23; 53(6):2063-74. PubMed ID: 21384409
    [Abstract] [Full Text] [Related]

  • 20. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE, Tyner VZ, Kim TH, Michalopoulos GK, Mars WM.
    Mod Pathol; 2003 Jan 23; 16(1):14-21. PubMed ID: 12527708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.